ICD-10-CM Billable Code

C81.1A

Nodular sclerosis Hodgkin lymphoma, in remission

Clinical Classification Guidelines

Medical Intelligence & Overview

Nodular sclerosis Hodgkin lymphoma is a type of Hodgkin's lymphoma, which is a cancer of the lymphatic system. When it is described as being 'in remission,' it means that the signs and symptoms of the disease are reduced or gone after treatment. This guide provides a clear understanding of this condition, including its causes, symptoms, diagnosis, and treatment options, tailored for patients and their families.

Causes & Symptoms

Clinical Causes: The exact cause of nodular sclerosis Hodgkin lymphoma remains unknown. However, it is believed to result from genetic changes in lymphocytes, a type of white blood cell involved in the immune response. Several factors may increase the risk of developing this disease, including: - Family history of Hodgkin lymphoma or other lymphatic cancers - Previous exposure to certain viruses, such as the Epstein-Barr virus - Personal history of other cancers or immune system disorders - Age, with higher prevalence among young adults and those over 55 - Socioeconomic factors, as some studies suggest a higher risk in developed countries

Key Symptoms: Patients with nodular sclerosis Hodgkin lymphoma may experience various signs and symptoms, which can include: - Swollen lymph nodes, often painless, in the neck, armpits, or groin - Fever that persists or recurs - Night sweats - Unexplained weight loss - Fatigue or weakness - Itching across the body - Persistent cough or chest pain if lymph nodes in the chest are involved - Abdominal discomfort or swelling, if lymph nodes in the abdomen are affected

Diagnostic & Treatment

Diagnosis Path: Diagnosing nodular sclerosis Hodgkin lymphoma involves several steps to confirm the presence of cancer and determine its stage. The process typically includes: - Physical examination to check for enlarged lymph nodes or other symptoms - Medical history review to identify risk factors - Imaging tests such as CT scans, PET scans, or MRI to locate affected areas - Lymph node biopsy, where a small tissue sample is removed and examined under a microscope for the characteristic Reed-Sternberg cells - Blood tests to evaluate overall health and organ function Once diagnosed, additional tests may be performed to assess the extent of the disease and to guide treatment planning.

Treatment Protocols: While individual treatment plans vary, common approaches for managing nodular sclerosis Hodgkin lymphoma include: - Chemotherapy: Drugs to kill cancer cells, often given in cycles - Radiation therapy: Targeted radiation to destroy remaining cancer cells in affected areas - Immunotherapy: Medications that help the immune system fight cancer - Stem cell transplant: In some cases, to restore healthy blood cells after intensive therapy When the disease is successfully treated, patients achieve remission, meaning no signs of cancer are detectable. In some cases, the disease can relapse, requiring additional treatment. - Remission indicates a positive response to treatment but requires ongoing monitoring to ensure the disease does not return.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C81.1A a billable ICD-10 code?
Yes, C81.1A is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C81.1A?
Clinical documentation must specify the nature of Nodular sclerosis Hodgkin lymphoma, in remission and any associated comorbidities for accurate reporting.

Cite this Clinical Reference